Stock listing
OTC:EXSNY Exosens Stock
US listing (OTC) of Exosens · home listing Euronext:EXENS
Follow Exosens into a list and get an email when it puts out news.
Share price · OTC:EXSNY
$18.50 USD 0.00 (0.0%)
Close on Nov 6, 2026
- Day range
- $18.50 – $18.50 USDNov 6, 2026
- Traded on an average day
- $135 USDMedian day 0 shares · 64 days with no trades · last 3 months, Aug 6, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:EXENS · Home | €50.00 EUR | -1.95 (-3.8%) | 98,864 | €51.55 | €51.60 | €50.00 | €51.95 | Close on Nov 20, 2026 |
| OTC:EXSNY | $18.50 USD | 0.00 (0.0%) | — | $18.50 | $18.50 | $18.50 | $18.50 | Close on Nov 6, 2026 |
| Frankfurt:H8Y | €49.20 EUR | -2.85 (-5.5%) | — | €51.75 | €51.75 | €49.20 | €52.05 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · OTC:EXSNY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 190 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 200 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | 0.00 | 0.0% | $18.50 | $18.50 | $18.50 | 0 | |
| $18.50 | +2.30 | +14.2% | $18.50 | $18.50 | $18.50 | 100 | |
| $16.20 | 0.00 | 0.0% | $16.20 | $16.20 | $16.20 | 0 | |
| $16.20 | 0.00 | 0.0% | $16.20 | $16.20 | $16.20 | 0 | |
| $16.20 | 0.00 | 0.0% | $16.20 | $16.20 | $16.20 | 0 |
- Ticker
- OTC:EXSNY
- Asset type
- Stock
- Sector
- Technology
- Industry
- Electronics & hardware
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 5, 2026
Exosens’ climate targets validated by the Science Based Targets initiative (SBTi)
Latest deck · Jul 28, 2026
H1 2026 Earnings Presentation
Earnings · 44 slides
Latest news
Exosens’ climate targets validated by the Science Based Targets initiative (SBTi)
Nov 5, 2026
Closed $18.50 (0.0%) on Nov 5, 2026
Monthly information on the total number of shares and voting rights in the share capital
Nov 2, 2026
Closed $18.50 (0.0%) on Nov 2, 2026
Exosens delivers +23.5% revenue growth in Q3 2026, driven by stronger demand and faster-than-expected capacity ramp-up; Fully on track to meet upgraded 2026 outlook
Oct 27, 2026
Closed $18.50 (0.0%) on Oct 27, 2026
Exosens supports the accelerating deployment of next-generation nuclear technologies in the U.S.
Oct 8, 2026
Closed $18.50 (0.0%) on Oct 8, 2026
Information mensuelle sur le nombre total d’actions et de droits de vote composant le capital social
Oct 1, 2026
Closed $18.50 (0.0%) on Oct 1, 2026
Exosens raises full-year 2026 guidance, driven by faster-than-expected capacity ramp-up and strong commercial momentum
Sep 17, 2026
Closed $18.50 (0.0%) on Sep 17, 2026
Exosens relève ses objectifs pour l’exercice 2026, grâce à une montée en cadence plus rapide que prévu des capacités de production et à une forte dynamique commerciale
Sep 16, 2026
Closed $18.50 (0.0%) on Sep 17, 2026
Photonis Defense se voit attribuer une première commande pour le programme BiNOD de l’U.S. Army, marquant une étape clé dans le développement d’Exosens aux États-Unis
Aug 24, 2026
Closed $18.50 (0.0%) on Aug 25, 2026
Exosens triples thermal camera production capacity to support accelerating demand for drone and counter-drone applications
Jul 28, 2026
Closed $16.20 (0.0%) on Jul 28, 2026
Exosens on 6ix
- Sector
- Technology
- Industry
- Electronics & hardware
- News releases
- 31 in the last 12 months · 44 in all · newest Nov 5, 2026 · oldest 2025
- Decks
- 9 decks · latest Jul 28, 2026
Where Exosens is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:EXENS · Home listing | Euronext | France | EUR |
| gettex:H8Y | gettex | Germany | EUR |
| LSIN:0EXO | LSIN | United Kingdom | EUR |
| LS Exchange:A40F75 | LS Exchange | Germany | EUR |
| Tradegate:H8Y | Tradegate | Germany | EUR |
| OTC:EXSNY · This page | OTC | United States | USD |
| OTC:EXOSF | OTC | United States | USD |
| Lang & Schwarz:A40F75 | Lang & Schwarz | Germany | EUR |
| Frankfurt:H8Y | Frankfurt | Germany | EUR |
| Turquoise:EXENSP | Turquoise | United Kingdom | EUR |
| Dusseldorf:H8Y | Dusseldorf | Germany | EUR |
| Munich:H8Y | Munich | Germany | EUR |
| Hamburg:H8Y | Hamburg | Germany | EUR |
| Stuttgart:H8Y | Stuttgart | Germany | EUR |
Valuation
P/E 59.3× against a median of 24.0×: 8th lowest of 10 Electronics & hardware companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- €2.70B EUR
- P/E
- 59.3×
- EV/sales
- 5.8×
- EV/EBITDA
- 19.0×
- Price/book
- 5.6×
- Gross margin
- 21.8%
- Operating margin
- 21.8%
- Net margin
- 9.1%
- Debt to equity
- 0.6×
- Beta
- No index for this market yet
Electronics & hardware: the 10 companies nearest in size, of 774 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Exosens · EURONEXT:EXENS | US$2.78B | US$2.96B | 59.3× | 5.8× | 19.0× | 5.6× | 9.1% | 0.6× | n/a |
| OSI Systems, Inc. · NASDAQ:OSIS | US$2.94B | US$3.64B | 18.5× | 2.0× | n/a | 3.8× | 8.8% | 1.3× | 1.12 |
| Suzhou Tianmai Thermal Technology Co. Ltd. Class A · SZSE:301626 | US$2.92B | US$2.96B | 115× | 8.3× | n/a | 10.8× | 7.2% | 0.6× | n/a |
| Zhejiang Wazam New Material Co., Ltd. Class A · SSE:603186 | US$2.90B | US$2.87B | 19.1× | 2.8× | n/a | 6.3× | 14.9% | 0.1× | n/a |
| Simmtech Co., Ltd. · KRX:222800 | US$2.79B | US$2.80B | n/a | 2.2× | 19.4× | 5.7× | −3.0% | 0.2× | n/a |
| Transcend Information, Inc. · TWSE:2451 | US$2.76B | US$2.18B | 3.7× | 1.7× | 2.5× | 2.4× | 57.2% | 0.0× | n/a |
| Walsin Technology Corporation · TWSE:2492 | US$2.76B | US$3.15B | 21.1× | 2.7× | 15.6× | 1.4× | 11.1% | 0.4× | n/a |
| Daeduck Electronics Co., Ltd. · KRX:353200 | US$2.73B | US$2.56B | 24.0× | 2.5× | 12.7× | 3.7× | 11.3% | 0.0× | n/a |
| Knowles Corporation · NYSE:KN | US$2.64B | US$2.71B | 36.9× | 4.1× | 20.1× | 3.3× | 10.8% | 0.1× | 1.86 |
| Netweb Technologies India Limited · NSE:NETWEB | US$2.63B | US$2.46B | 66.5× | 6.1× | 43.1× | 11.6× | 9.8% | 0.2× | n/a |
| Aoshikang Technology Co. Ltd. Class A · SZSE:002913 | US$2.62B | US$2.60B | 36.4× | 2.6× | n/a | 3.7× | 7.3% | 0.3× | n/a |
| Median of the others | US$2.76B | US$2.75B | 24.0× | 2.6× | 17.5× | 3.8× | 10.3% | 0.2× | 1.49 |
Forecasts
Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 69.85 EUR · Analysts' mean
- EPS, year to Dec 2026
- 1.92 · 9 analysts
- Revenue, year to Dec 2026
- 565.4M · 10 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Jérôme Cerisier | Chief Executive Officer and director |
| Laurent Sfaxi | Investor Relations |
| Salim Helou | Director - Represented by Salim Helou |
Board
| Director | Role |
|---|---|
| Jean-Hubert Vial | Chairman of the Board of Directors |
| Brigitte Geny | Independent Director |
| Christophe Bernardini | Director |
| Dorianne Bonfils | Independent Director - Represented by Dorianne Bonfils |
| François Calvarin | Censor |
| Jérôme Cerisier | Chief Executive Officer and director |
| Michel Mariton | Independent Director |
| Wendy Kool-Foulon | Independent Director |
Events
- Next results
- Feb 22, 2027 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Oct 27, 2026 · After close | +0.7% |
| Quarter to Mar 31, 2026 | Apr 27, 2026 · After close | +0.2% |
| Q4 2025 | Feb 23, 2026 · After close | +5.4% |
| Quarter to Sep 30, 2025 | Oct 27, 2025 | −0.4% |
| Q2 2025 | Jul 30, 2025 | +11.3% |
| Quarter to Mar 31, 2025 | Apr 28, 2025 | −3.9% |
| Quarter to Sep 30, 2024 | Oct 28, 2024 | +0.7% |
| Q2 2024 | Sep 3, 2024 | +5.9% |
| Q1 2024 | May 29, 2024 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026 Earnings Presentation | Earnings | 44 slides | Jul 28, 2026 |
| Shareholder Meeting (May 2026) | Shareholder meeting | 79 slides | May 22, 2026 |
| FY2025 Earnings Presentation | Earnings | 59 slides | Feb 23, 2026 |
| H1 2025 Earnings Presentation | Earnings | 43 slides | Jul 30, 2025 |
| Shareholder Meeting (May 2025) | Shareholder meeting | 80 slides | May 23, 2025 |
| Technical Presentation (March 2025) | Technical | 25 slides | Mar 27, 2025 |
| FY2024 Earnings Presentation | Earnings | 52 slides | Mar 3, 2025 |
| H1 2024 Earnings Presentation | Earnings | 37 slides | Sep 3, 2024 |
| Investor Presentation (February 2024) | Investor deck | 18 slides | Feb 1, 2024 |
Financials
Annual, in EUR
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 468.2M | 383.4M | 291.8M | 200.8M | 166.2M | 149.9M |
| Cost of revenue | 366.0M | 168.5M | 142.0M | 86.8M | 66.1M | 58.0M |
| Gross profit | 102.2M | 225.6M | 176.8M | 114.0M | 100.0M | 91.8M |
| Research and development | 9.10M | 3.50M | 6.34M | 4.85M | ||
| Selling, general and administrative | 141.3M | 112.5M | 82.9M | 63.2M | 57.0M | 52.9M |
| Operating income | 102.0M | 76.8M | 48.3M | 30.4M | 32.0M | 30.7M |
| Depreciation and amortization | 39.9M | 31.6M | 28.1M | 19.0M | 11.5M | 7.86M |
| EBITDA | 141.9M | 108.4M | 76.4M | 49.4M | 43.4M | 38.6M |
| Interest expense | 13.8M | 27.8M | 30.8M | 15.2M | 37.6M | 41.9M |
| Income before tax | 88.2M | 45.7M | 20.2M | 17.1M | -150.3M | -13.2M |
| Income tax | 18.0M | 11.6M | 1.83M | 5.89M | -1.30M | 2.59M |
| Net income | 42.7M | 30.7M | 18.4M | 11.2M | -149.0M | -15.8M |
| Earnings per share, basic | 0.84 | 0.61 | 0.24 | 0.37 | -4.90 | -0.52 |
| Earnings per share, diluted | 0.84 | 0.61 | 0.24 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 68.6M | 117.2M | 15.5M | 29.0M | 15.9M | 31.1M |
| Short-term investments | 33.3M | 33.0M | 70.0K | 50.0K | 2.41M | 594.0K |
| Receivables | 73.1M | 71.0M | 69.2M | 32.7M | 35.6M | 28.1M |
| Inventory | 105.1M | 93.0M | 78.5M | 55.7M | 45.0M | 46.2M |
| Current assets | 280.2M | 314.2M | 192.7M | 144.7M | 112.7M | 119.4M |
| Property, plant and equipment | 113.1M | 93.6M | 72.1M | 60.5M | ||
| Goodwill | 233.3M | 189.5M | 174.3M | 139.6M | 257.6M | 400.0M |
| Total assets | 878.9M | 817.0M | 656.4M | 529.3M | 460.5M | 598.1M |
| Accounts payable | 31.2M | 26.0M | 32.3M | 22.9M | 15.9M | 10.7M |
| Current liabilities | 113.7M | 107.0M | 110.1M | 72.5M | 53.5M | 59.0M |
| Long-term debt | 249.3M | 247.8M | 300.8M | 238.4M | 199.3M | |
| Total debt | 249.8M | 250.2M | 307.9M | 255.3M | 208.1M | 451.6M |
| Total liabilities | 433.3M | 404.4M | 452.3M | 346.2M | 288.4M | 501.0M |
| Shareholders' equity | 445.7M | 412.6M | 204.1M | 183.1M | 172.1M | 97.1M |
| Shares outstanding | 50.9M | 50.8M | 30.4M | 30.4M | 30.4M | 30.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | 107.3M | 98.7M | 50.5M | 47.5M | 42.7M | 44.1M |
| Capital spending | -50.1M | -41.3M | -30.9M | -21.8M | -19.6M | -13.8M |
| Free cash flow | 48.5M | 96.2M | 19.5M | 25.7M | 23.1M | 30.4M |
| Cash from investing | -121.2M | -71.4M | -99.6M | -55.5M | -21.3M | -13.8M |
| Cash from financing | -25.2M | 76.9M | 35.5M | 20.3M | -36.8M | -5.01M |
| Dividends paid | -5.08M | 0 | ||||
| Share buybacks | -5.60M | -300.0K | 0 | 0 | ||
| Change in cash | -39.8M | 104.6M | -13.5M | 12.4M | -15.2M | 25.1M |
Filings
Cap table
Built by 6ix from Exosens’ releases
- Common shares
- 50,683,535
- Fully diluted
- 50,683,535
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 50,683,535 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 50,683,535 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Brigitte Geny | Independent Director · Since at least May 29, 2026 |
| Christophe Bernardini | Director · Since at least Nov 5, 2026 |
| Dorianne Bonfils | Independent Director - Represented by Dorianne Bonfils · Since at least May 26, 2025 |
| François Calvarin | Censor · Since at least Nov 5, 2026 |
| Jean-Hubert Vial | Chairman of the Board of Directors · Since at least May 29, 2026 |
| Jérôme Cerisier | Chief Executive Officer and director · Since at least Sep 17, 2026 |
| Laurent Sfaxi | Investor Relations · Since at least Sep 17, 2026 |
| Michel Mariton | Independent Director · Since at least May 29, 2026 |
| Salim Helou | Director - Represented by Salim Helou · Since at least Nov 5, 2026 |
| Wendy Kool-Foulon | Independent Director · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Exosens.